로딩 중…
지수 로딩 중…
Caregen
214370· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩71,200+1.86%
2026-06-19
Price Chart
Caregen+135.37%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 3.82T KRW |
| Revenue | 74.22B KRW |
| Net Income | -16.9M KRW |
| Total Assets | 245.37B KRW |
| Net Assets | 214.47B KRW |
| Employees | 193 |
| Value | |
| P/B | 17.83x |
| P/S | 51.53x |
| FCF Yield | 0.39% |
| Profitability | |
| ROE | -0.01% |
| ROA | -0.01% |
| Op. Margin | -9.47% |
| Revenue Growth | 6.63% |
| Earnings Growth | 38.72% |
| Financial Health | |
| Debt Ratio | 114.41% |
| Total Debt | 0 KRW |
| FCF | 14.73B KRW |
| Cash | 13.16B KRW |
| Current Ratio | 4.80x |
| Dividend | |
| Div. Yield | 0.63% |
| Div. Growth | -31.72% |
| Performance | |
| 1Y Return | 135.37% |
| 1M Return | -23.61% |
| From 52W High | -53.71% |
| 1Y MDD | -54.56% |
| Trading | |
| Volume | 79,471 shares |
| Foreign Own. | 3.98% |
| Per Share | |
| EPS | 435 KRW |
| BPS | 4,388 KRW |
Company Info
Caregen, established in 2001 and listed on KOSDAQ in 2015, is a biotechnology company headquartered in Gangnam-gu, Seoul. It researches and develops peptides and growth factor proteins, selling professional therapy products, functional cosmetics, and health functional foods in 130 countries. The company has built a peptide library with 833 domestic and international patent registrations and is developing new drug pipelines for conditions like macular degeneration, diabetes, and hair loss. Caregen is also expanding its business into new areas such as specialized animal pharmaceuticals and functional feeds.